AF
DYN icon

Allworth Financial’s Dyne Therapeutics DYN Stock Holding History

Allworth Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.9K Buy
2,787
+459
+20% +$8.53K ﹤0.01% 2296
2026
Q1 		$42.2K Buy
2,328
+1,769
+316% +$30.5K ﹤0.01% 2451
2025
Q4 		$10.9K Buy
559
+64
+13% +$1.21K ﹤0.01% 3211
2025
Q3 		$6.26K Buy
495
+20
+4% +$228 ﹤0.01% 3415
2025
Q2 		$4.52K Sell
475
-23
-5% -$253 ﹤0.01% 3315
2025
Q1 		$5.53K Buy
+498
New +$7.12K ﹤0.01% 2704
2024
Q4 		– Sell
-5
Closed -$180 – 3970
2024
Q3 		$180 Hold
5
– – ﹤0.01% 3618
2024
Q2 		$208 Buy
+5
New +$145 ﹤0.01% 3543

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allworth Financial's DYN Position: Q2 2026 in Review

Allworth Financial increased its Dyne Therapeutics (DYN) stake by 20% in Q2 2026, buying an estimated $8.53K and bringing the position to 2,787 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Allworth Financial first reported a position in DYN in Q2 2024 and has held it in 8 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Allworth Financial held 2,787 shares of Dyne Therapeutics worth $61.9K as of Q2 2026.
  • Allworth Financial bought 459 Dyne Therapeutics shares in Q2 2026, an estimated $8.53K.
  • Dyne Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2296 holding.
  • Allworth Financial first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.